Pivotal bioVenture Partners Investment Advisor LLC
Venture CapitalTop Portfolio Positions
12 positions ·
$279,605,926 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| PCVX |
Vaxcyte, Inc.
Healthcare
|
1,372,425 | $79,751,616 | 28.52% | |
| OCS |
Oculis Holding AG
Healthcare
|
1,680,283 | $44,678,724 | 15.98% | |
| EVMN |
Evommune, Inc.
Healthcare
|
1,926,943 | $44,300,419 | 15.84% | |
| ARQT |
Arcutis Biotherapeutics, Inc.
Healthcare
|
1,355,892 | $31,944,815 | 11.42% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
1,553,726 | $18,535,951 | 6.63% | |
| IMNM |
Immunome Inc.
Healthcare
|
732,512 | $16,020,037 | 5.73% | |
| MPLT |
MapLight Therapeutics, Inc.
Healthcare
|
611,447 | $12,430,717 | 4.45% | |
| ZBIO |
Zenas BioPharma, Inc.
Healthcare
|
591,991 | $11,573,424 | 4.14% | |
| BIOA |
BioAge Labs, Inc.
Healthcare
|
653,374 | $11,427,511 | 4.09% | |
| AVTX |
Avalo Therapeutics, Inc.
Healthcare
|
295,933 | $4,418,279 | 1.58% |
Portfolio Trend
22 quarters · across all stocks
Holdings in IMNM
Shares Held
Position Value (USD)
3 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,020,037 | 732,512 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $15,734,357 | 732,512 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $5,884,415 | 502,512 | Shares | Defined | 2025-11-13 | |
| No 13F history on record for this holder in this stock. | ||||||